Abstract
Epithelial-mesenchymal transition (EMT) contributes to the development of severe lung diseases, such as pulmonary fibrosis. Recently, it has been reported that EMT involves complex metabolic reprogramming triggered by several factors including transforming growth factor (TGF-β1) and that monocarboxylate transporter (MCT1) plays an essential role in these metabolic changes. The aim of the present study was to clarify the functional expression of MCT1 during TGF-β1-induced EMT in alveolar epithelial A549 cells. The transport function of MCT1 in A549 cells was examined using [3H]γ-hydroxybutyrate (GHB) and [3H] lactic acid (LA) as substrates and α-cyano-4-hydroxycinnamate (CHC), lactic acid, phloretin, and AR-C155858 (AR) as inhibitors of MCT1. EMT was induced by treating the cells with TGF-β1. mRNA and protein expression levels were analyzed using real-time PCR and Western blotting, respectively. Time-, temperature-, and pH-dependent GHB and LA uptake were observed in A549 cells. CHC, lactic acid, phloretin, and AR significantly inhibited the uptake of GHB in a concentration-dependent manner, suggesting that MCT1 is primarily responsible for transport of monocarboxylates such as GHB and LA in A549 cells. TGF-β1 treatment significantly enhanced GHB and LA uptake as well as the mRNA and protein expression levels of MCT1 in A549 cells. These changes were neutralized by co-treatment with SB431542, an inhibitor for the TGF-β1 signaling pathway. CHC and AR had no effect on TGF-β1-induced EMT-related gene expression changes. Here, we have clearly characterized functional expression of MCT1 in A549 cells and have shown that MCT1 may be upregulated via the TGF-β1 signaling pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CK19:
-
cytokeratin 19
- EMT:
-
epithelial-mesenchymal transition
- GHB:
-
γ-hydroxybutyrate
- SB:
-
SB431542
- α-SMA:
-
α-smooth muscle actin
- TGF-β1:
-
transforming growth factor-β1
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
References
Bröer S, Bröer A, Schneider HP, Stegen C, Halestrap AP, Deitmer JW (1999) Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem J 341:529–535. https://doi.org/10.1042/0264-6021:3410529
Choi J-W, Kim Y, Lee J-H, Kim Y-S (2014) Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder. Urology 84:245.e9–245.15. https://doi.org/10.1016/j.urology.2014.03.031
Connolly EC, Freimuth J, Akhurst RJ (2012) Complexities of TGF-β targeted cancer therapy. Int J Biol Sci 8:964–978. https://doi.org/10.7150/ijbs.4564
Doherty JR, Yang C, Scott KE, Cameron MD, Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, Tortosa M, Genau HM, Rounbehler RJ, Lu Y, Dang CV, Kumar KG, Butler AA, Bannister TD, Hooper AT, Unsal-Kacmaz K, Roush WR, Cleveland JL (2014) Blocking lactate export by inhibiting the Myc target MCT1 diables glycolysis and glutathione synthesis. Cancer Res 74:908–920. https://doi.org/10.1158/0008-5472.CAN-13-2034
Eilertsen M, Andersen S, Al-Saad S et al (2014) Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival. PLoS One 9:e105038. https://doi.org/10.1371/journal.pone.0105038
Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML (2006) The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 70:2108–2115. https://doi.org/10.1124/mol.106.026245
Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92:329–333. https://doi.org/10.1016/j.radonc.2009.06.025
Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, de Donatis A, Lanciotti M, Serni S, Cirri P, Chiarugi P (2012) Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 72:5130–5140. https://doi.org/10.1158/0008-5472.CAN-12-1949
Fishbein WN, Merezhinskaya N, Foellmer JW (2002) Relative distribution of three major lactate transporters in frozen human tissues and their localization in unfixed skeletal muscle. Muscle Nerve 26:101–112. https://doi.org/10.1002/mus.10168
Gray AL, Coleman DT, Shi R, Cardelli JA (2016) Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity. Oncotarget 7:32695–32706. https://doi.org/10.18632/oncotarget.9016
Guan X, Ruszaj D, Morris ME (2018) Development and validation of a liquid chromatography tandem mass spectrometry assay for AZD3965 in mouse plasma and tumor tissue: application to pharmacokinetic and breast tumor xenograft studies. J Pharm Biomed Anal 155:270–275. https://doi.org/10.1016/j.jpba.2018.03.061
Guan X, Rodriguez-Cruz V, Morris ME (2019) Cellular uptake of MCT1 inhibitors AR-C155858 and AZD3965 and their effects on MCT-mediated transport of l-lactate in murine 4T1 breast tumor cancer cells. AAPS J 21:13. https://doi.org/10.1208/s12248-018-0279-5
Halestrap AP, Meredith D (2004) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447:619–628. https://doi.org/10.1007/s00424-003-1067-2
Halestrap AP, Wilson MC (2012) The monocarboxylate transporter family--role and regulation. IUBMB Life 64:109–119. https://doi.org/10.1002/iub.572
Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776–1784. https://doi.org/10.1172/JCI20530
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428. https://doi.org/10.1172/JCI39104
Kang H, Kim H, Lee S et al (2019) Role of metabolic reprogramming in epithelial–mesenchymal transition (EMT). Int J Mol Sci 20:2042. https://doi.org/10.3390/ijms20082042
Kawami M, Harabayashi R, Miyamoto M, Harada R, Yumoto R, Takano M (2016) Methotrexate-induced epithelial–mesenchymal transition in the alveolar epithelial cell line A549. Lung 194:923–930. https://doi.org/10.1007/s00408-016-9935-7
Kawami M, Deguchi J, Yumoto R, Sakakibara N, Tsukamoto I, Konishi R, Takano M (2017) Effect of COA-cl on transforming growth factor-β1-induced epithelial-mesenchymal transition in RLE/Abca3 cells. Drug Metab Pharmacokinet 32:224–227. https://doi.org/10.1016/j.dmpk.2017.05.001
Kawami M, Harabayashi R, Harada R, Yamagami Y, Yumoto R, Takano M (2018a) Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549. Biochem Biophys Res Commun 497:457–463. https://doi.org/10.1016/j.bbrc.2018.02.111
Kawami M, Yamada Y, Issarachot O, Junyaprasert VB, Yumoto R, Takano M (2018b) P-gp modulating effect of Azadirachta indica extract in multidrug-resistant cancer cell lines. Pharmazie 73:104–109. https://doi.org/10.1691/ph.2018.7116
Kottmann RM, Kulkarni AA, Smolnycki KA, Lyda E, Dahanayake T, Salibi R, Honnons S, Jones C, Isern NG, Hu JZ, Nathan SD, Grant G, Phipps RP, Sime PJ (2012) Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med 186:740–751. https://doi.org/10.1164/rccm.201201-0084OC
Lieber M, Smith B, Szakal A et al (1976) A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62–70
Liu M, Quek L-E, Sultani G, Turner N (2016) Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma. Cancer Metab 4:19. https://doi.org/10.1186/s40170-016-0160-x
Lottes RG, Newton DA, Spyropoulos DD, Baatz JE (2014) Alveolar type II cells maintain bioenergetic homeostasis in hypoxia through metabolic and molecular adaptation. Am J Physiol Lung Cell Mol Physiol 306:L947–L955. https://doi.org/10.1152/ajplung.00298.2013
Lottes RG, Newton DA, Spyropoulos DD, Baatz JE (2015) Lactate as substrate for mitochondrial respiration in alveolar epithelial type II cells. Am J Physiol Lung Cell Mol Physiol 308:L953–L961. https://doi.org/10.1152/ajplung.00335.2014
Morais-Santos F, Granja S, Miranda-Gonçalves V, Moreira AH, Queirós S, Vilaça JL, Schmitt FC, Longatto-Filho A, Paredes J, Baltazar F, Pinheiro C (2015) Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget 6:19177–19189. https://doi.org/10.18632/oncotarget.3910
Morandi A, Taddei ML, Chiarugi P, Giannoni E (2017) Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol 7:40. https://doi.org/10.3389/fonc.2017.00040
Payen VL, Mina E, Van Hee VF, Porporato PE, Sonveaux P (2019) Monocarboxylate transporters in cancer. Mol Metab. https://doi.org/10.1016/j.molmet.2019.07.006
Pinheiro C, Longatto-Fiho A, Azevedo-Silva J et al (2012) Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44:127–139. https://doi.org/10.1007/s10863-012-9428-1
Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, Springer TA (2011) Latent TGF-β structure and activation. Nature 474:343–349. https://doi.org/10.1038/nature10152
Takano M, Yamamoto C, Yamaguchi K et al (2015) Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3. Drug Metab Pharmacokint 30:111–118. https://doi.org/10.1016/j.dmpk.2014.10.007
Tuder RM, Lara AR, Thannickal VJ (2012) Lactate, a novel trigger of transforming growth factor-β activation in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 186:701–703. https://doi.org/10.1164/rccm.201208-1491ED
Ullah MS, Davies AJ, Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 281:9030–9037. https://doi.org/10.1074/jbc.M511397200
Willis BC, Borok Z (2007) TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293:L535–L534. https://doi.org/10.1152/ajplung.00163.2007
Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu RM, Bernard K, Thannickal VJ, Liu G (2015) Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med 192:1462–1474. https://doi.org/10.1164/rccm.201504-0780OC
Zank DC, Bueno M, Mora AL, Rojas M (2018) Idiopathic pulmonary fibrosis: aging, mitochondrial dysfunction, and cellular bioenergetics. Front Med 5:10. https://doi.org/10.3389/fmed.2018.00010
Zhang G, Zhang Y, Dong D, Wang F, Ma X, Guan F, Sun L (2018) MCT1 regulates aggressive and metabolic phenotypes in bladder cancer. J Cancer 9:2492–2501. https://doi.org/10.7150/jca.25257
Funding
This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS) (numbers; 26293033, 15 K08074, and 16 K18945).
Author information
Authors and Affiliations
Contributions
MU and MK designed and performed the experiments, analyzed the data, and wrote the manuscript. RY and MT discussed the results and edited and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PPTX 60 kb)
Rights and permissions
About this article
Cite this article
Uddin, M., Kawami, M., Yumoto, R. et al. Effect of transforming growth factor-β1 on functional expression of monocarboxylate transporter 1 in alveolar epithelial A549 cells. Naunyn-Schmiedeberg's Arch Pharmacol 393, 889–896 (2020). https://doi.org/10.1007/s00210-019-01802-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-019-01802-3